3/11
08:15 am
fenc
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Medium
Report
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
3/10
10:06 pm
fenc
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
Low
Report
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
3/10
09:17 am
fenc
Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain [Yahoo! Finance]
High
Report
Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain [Yahoo! Finance]
3/10
06:03 am
fenc
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
High
Report
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
3/6
04:22 pm
fenc
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025
Low
Report
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025
2/7
07:00 am
fenc
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
Low
Report
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany